Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hans Herfarth, MD, PhD
University of North Carolina
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Yale University School of Medicine
New Haven, Connecticut, United States
Jill Gaidos, MDRecruiting - University of Iowa
Iowa City, Iowa, United States
Steven Polyak, MDRecruiting - Mercy Medical Center
Baltimore, Maryland, United States
Ray Cross, MDRecruiting - Brigham and Women'S Hospital
Boston, Massachusetts, United States
Jessica Allegretti, MDRecruiting - New York University
New York, New York, United States
David Hudesman, MDRecruiting - University of North Carolina
Chapel Hill, North Carolina, United States
Hans Herfarth, MD, PhDRecruiting - Atrium Health Center for Gastroenterology and Surgery
Charlotte, North Carolina, United States
Maithili Chitnavis, MDRecruiting - Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
Richard Bloomfeld, MDRecruiting - University of Cincinnati
Cincinnati, Ohio, United States
Loren Brook, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Nov 2025
- Primary completion
- 3 Nov 2028
- Completion
- 3 Nov 2028
- Last update posted
- 26 May 2026
- Registered enrollment
- 200
- Registry id
- NCT07237516
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.